...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Almost 1.25 years now
Reply New Message
Prev Message Back To Forum Threaded View Next Message

kbc

I'd be happy and surprised if any type of good deal happens within 6 months to be honest. But I keep hoping.

As Don stated at one of his updates, things happen quickly in cancer trials vs. cardio. I sort of hope that quick really means quick.

Cheers

Toinv

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply